Havana  —  Cuba has started a mass vaccination campaign against Covid-19 using one of its five home-grown vaccine candidates which, if proven effective, could improve access to inoculations across Latin America, one of the regions hardest hit by the pandemic.

Cuba’s state-run biopharmaceutical sector, which has a history of developing, producing and exporting serums, has concluded late-phase trials for the vaccine, Abdala, in more than 48,000 volunteers but not yet published the results...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.